Cyclin-dependent kinase (CDK) and glycolene synthase kinase-3 (GSK-3) inhibitors

Details for Australian Patent Application No. 2002225096 (hide)

International Classifications

Event Publications

13 July 2006 Application Accepted

Published as AU-B-2002225096

27 July 2006 Corrigenda

Applications Accepted - Name Index Under the names Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.), Application No. 2002225096, under INID (54) correct the title to read Cyclin-dependent kinase (CDK) and glycogen synthase kinase-3 (GSK-3) inhibitors.

9 November 2006 Standard Patent Sealed

12 March 2009 Alteration of Name

The name of the patentee has been altered to IPSEN Pharma S.A.S

14 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.